The ALT was significantly higher in the glutamine arm (p = 0.000) at week 12, this is due to the patient who developed SCH and was statistically significantly higher at week 24 (p < 0.001) but non-clinically significant as all values were within normal range. This evidence concerns the gene GPT and spindle cell hemangioma.